EFTA Document EFTA01479577

Subject: Re: Biotech Update... Gilead beat, shares halted [C] From: Tazia Smith < E> Date: Tue, 22 Apr 2014 16:16:17 -0400 To: jeevacation@gmail.com Cc: Nav Gupta Paul Morris Vahe Stepanian Vinit Sahni Classification: Confidential Jeffrey - sure you see this, just making sure, Gilead shares are halted in the after-market following a significant top and bottom-line earnings beat ($1.48 vs $0.92 cons eps, $5bn on the topline vs. expecations of $3.96bn) as you know, you're long 8100 sha